Identification of Cell Cycle Regulatory Genes as Principal Targets of p53-mediated Transcriptional Repression

p53 Mutations in Human Cancers

Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018 · see citing works

p53, guardian of the genome

Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138 · see citing works

The p53 tumour suppressor gene

Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785 · see citing works

Live or let die: the cell's response to p53

Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,177 · see citing works

Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.

Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133 · see citing works

A model for p53-induced apoptosis

Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500 · see citing works

Identifying biological themes within lists of genes with EASE

Hosack, D. A., Dennis, G., Sherman, B. T., Lane, H. C., & Lempicki, R. A. (2003) · Genome biology · doi:10.1186/gb-2003-4-10-r70 · Cited by 1,950 · see citing works

p53 Has a Direct Apoptogenic Role at the Mitochondria

Mihara, M., Erster, S. H., Zaika, A. I., Petrenko, O., Chittenden, T. D., Pančoška, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,771 · see citing works

Identification of Genes Periodically Expressed in the Human Cell Cycle and Their Expression in Tumors

Whitfield, M. L., Sherlock, G., Saldanha, A. J., Murray, J. I., Ball, C. A., Alexander, K. E., Matese, J. C., Perou, C. M., Hurt, M. M., Brown, P. O., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0030 · Cited by 1,527 · see citing works

E2F integrates cell cycle progression with DNA repair, replication, and G ₂ /M checkpoints

Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R. A., & Dynlacht, B. D. (2002) · Genes & Development · doi:10.1101/gad.949802 · Cited by 1,125 · see citing works

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

McDonnell, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C. J., Chung, L. W. K., Hsieh, J., Tu, S., & Campbell, M. L. (1992) · PubMed · Cited by 1,049 · see citing works

Database of p53 gene somatic mutations in human tumors and cell lines.

Hollstein, M. C., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sørlie, T., Hovig, E. J., Smith‐Sørensen, B., Montesano, R., & Harris, C. C. (1994) · Europe PMC (PubMed Central) · Cited by 860 · see citing works

Regulation ofp53downstream genes

El‐Deiry, W. S. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0097 · Cited by 797 · see citing works

Rapid Destruction of Human Cdc25A in Response to DNA Damage

Mailand, N., Falck, J., Lukas, C., Syljuåsen, R. G., Welcker, M., Bartek, J., & Lukas, J. (2000) · Science · doi:10.1126/science.288.5470.1425 · Cited by 787 · see citing works

Identification of a p53-dependent negative response element in the bcl-2 gene.

Miyashita, T., Harigai, M., Hanada, M., & Reed, J. C. (1994) · PubMed · Cited by 746 · see citing works

Targeted disruption of the three Rb-related genes leads to loss of G ₁ control and immortalization

Sage, J., Mulligan, G. J., Attardi, L. D., Miller, A., Chen, S., Williams, B., Theodorou, E., & Jacks, T. (2000) · Genes & Development · doi:10.1101/gad.843200 · Cited by 582 · see citing works

Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3aPreprint

Murphy, M. E., Ahn, J., Walker, K. K., Hoffman, W. H., Evans, R. M., Levine, A. J., & George, D. L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2490 · Cited by 455 · see citing works

Initiating DNA synthesis: from recruiting to activating the MCM complex

Lei, M., & Tye, B. K. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.8.1447 · Cited by 365 · see citing works

DNA microarrays identification of primary and secondary target genes regulated by p53

Kannan, K., Amariglio, N., Rechavi, G., Jacob‐Hirsch, J., Kela, I., Kaminski, N., Getz, G. A., Domany, E., & Givol, D. (2001) · Oncogene · doi:10.1038/sj.onc.1204319 · Cited by 331 · see citing works

p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest

Ho, J. S. L., Ma, W., Mao, D. Y. L., & Benchimol, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7423-7431.2005 · Cited by 312 · see citing works

p53 oncogene mutations in three human prostate cancer cell lines

Carroll, A. G., Voeller, H. J., Sugars, L. V. Y., & Gelmann, E. P. (1993) · The Prostate · doi:10.1002/pros.2990230206 · Cited by 303 · see citing works

Genome-Wide In Silico Identification of Transcriptional Regulators Controlling the Cell Cycle in Human CellsPreprint

Elkon, R., Linhart, C., Sharan, R., Ron Shamir, A., & Shiloh, Y. (2003) · Genome Research · doi:10.1101/gr.947203 · Cited by 297 · see citing works

The p53MH algorithm and its application in detecting p53-responsive genes

Hoh, J., Jin, S. V., Parrado, T., Edington, J., Levine, A. J., & Ott, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132268899 · Cited by 295 · see citing works

A polymorphic microsatellite that mediates induction of PIG3 by p53

Contente, A., Dittmer, A., Koch, M. C., Roth, J., & Dobbelstein, M. (2002) · Nature Genetics · doi:10.1038/ng836 · Cited by 274 · see citing works

High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.

Zhang, W. W., Fang, X., Mazur, W. M., French, B. A., Georges, R. N., & Roth, J. A. (1994) · PubMed · Cited by 257 · see citing works

p21/CDKN1A Mediates Negative Regulation of Transcription by p53

Löhr, K., Möritz, C., Contente, A., & Dobbelstein, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212517200 · Cited by 227 · see citing works

Wild-type p53 negatively regulates the expression of a microtubule-associated protein.Preprint

Murphy, M. E., Hinman, A. M., & Levine, A. J. (1996) · Genes & Development · doi:10.1101/gad.10.23.2971 · Cited by 221 · see citing works

Direct p53 Transcriptional Repression: In Vivo Analysis of CCAAT-Containing G2/M Promoters

Imbriano, C., Gurtner, A., Cocchiarella, F., Agostino, S. D., Basile, V., Gostissa, M., Dobbelstein, M., Sal, G. D., Piaggio, G., & Mantovani, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3737-3751.2005 · Cited by 205 · see citing works

Transcriptional repression mediated by the p53 tumour suppressor

Ho, J., & Benchimol, S. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401191 · Cited by 200 · see citing works

The tumour suppressor protein p53 can repress transcription of cyclin B

Krause, K. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.22.4410 · Cited by 170 · see citing works

Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters

Estève, P., Chin, H. G., & Pradhan, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407729102 · Cited by 165 · see citing works

DNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms

Clair, S. S., Giono, L. E., Varmeh, S., Resnick‐Silverman, L., Liu, W.-J., Padi, A., Dastidar, J., DaCosta, A., Mattia, M., & Manfredi, J. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.002 · Cited by 162 · see citing works

Transcriptional Repression by p53 through Direct Binding to a Novel DNA Element

Johnson, R. A., Ince, T. A., & Scotto, K. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100121200 · Cited by 158 · see citing works

p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor

Yun, J., Chae, H., Choy, H. E., Chung, J., Yoo, H., Han, M.-H., & Shin, D. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29677 · Cited by 155 · see citing works

Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line.

McConkey, D. J., Greene, G., & Pettaway, C. A. (1996) · PubMed · Cited by 153 · see citing works

p53-regulated Transcriptional Program Associated with Genotoxic Stress-induced Apoptosis

Kho, P. S., Wang, Z., Zhuang, L., Li, Y., Chew, J.-L., Ng, H., Liu, E. T., & Yu, Q. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311912200 · Cited by 143 · see citing works

TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2

Munshi, A., Pappas, G., Honda, T., McDonnell, T. J., Younes, A., Li, Y., & Meyn, R. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204504 · Cited by 117 · see citing works

p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53

Taylor, W. R., Schönthal, A. H., Galante, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005101200 · Cited by 110 · see citing works

Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes

Rubin, S. J., Hallahan, D. E., Ashman, C. R., Brachman, D. G., Beckett, M. A., Virudachalam, S., Yandell, D. W., & Weichselbaum, R. R. (1991) · Journal of Surgical Oncology · doi:10.1002/jso.2930460108 · Cited by 107 · see citing works

p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor

Jung, M.-S., Yun, J., Chae, H., Kim, J., Kim, S., Choi, T.-S., & Shin, D. Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204748 · Cited by 93 · see citing works

p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2

Jackson, M. W., Agarwal, M. K., Yang, J., Bruss, P., Uchiumi, T., Agarwal, M. L., Stark, G. R., & Taylor (2005) · Journal of Cell Science · doi:10.1242/jcs.02307 · Cited by 92 · see citing works

Bcl-2 inhibits p53 nuclear import following DNA damage

Beham, A. W., Marín, M. C., Fernandez, A., Herrmann, J. L., Brisbay, S. M., Tari, A. M., Lopez‐Berestein, G., Lozano, G., Sarkiss, M. G., & McDonnell, T. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201464 · Cited by 86 · see citing works

E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress

Polager, S., & Ginsberg, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210327200 · Cited by 70 · see citing works

Inhibition of p53 Transcriptional Activity by Bcl-2 Requires Its Membrane-anchoring Domain

Froesch, B. A., Aimé, C., Leber, B. F., Andrews, D. W., & Reed, J. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6469 · Cited by 63 · see citing works

Transcriptional Regulation of Mitotic Checkpoint Gene MAD1 by p53

Chun, A. C. S., & Jin, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307185200 · Cited by 60 · see citing works

Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis

Li, C., Lin, M., & Liu, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208114 · Cited by 58 · see citing works

p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line

Badie, C., Bourhis, J., Sobczak‐Thépot, J., Haddada, H., Chiron, M., Janicot, M., Janot, F., Tursz, T., & Vassal, G. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0976 · Cited by 47 · see citing works

Negative Regulation of Chk2 Expression by p53 Is Dependent on the CCAAT-binding Transcription Factor NF-Y

Matsui, T., Katsuno, Y., Inoue, T., Fujita, F., Joh, T., Niida, H., Murakami, H., Itoh, M., & Nakanishi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403232200 · Cited by 47 · see citing works

Cell Cycle Checkpoint Proteins and Cellular Response to Treatment by Anticancer Agents

Damia, G. L. M., & Broggini, M. (2004) · Cell Cycle · doi:10.4161/cc.3.1.631 · Cited by 45 · see citing works

A comparative analysis of data generated using two different target preparation methods for hybridization to high-density oligonucleotide microarrays

Gold, D. L., Coombes, K. R., Medhane, D., Ramaswamy, A., Ju, Z., Strong, L. C., Koo, J. S., & Kapoor, M. (2004) · BMC Genomics · doi:10.1186/1471-2164-5-2 · Cited by 44 · see citing works

A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells

Spurgers, K. B., Coombes, K. R., Meyn, R. E., Gold, D. L., Logothetis, C. J., Johnson, T. J., & McDonnell, T. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207293 · Cited by 13 · see citing works

A microRNA component of the p53 tumour suppressor network

He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692 · see citing works

The miR-34 family in cancer and apoptosis

Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236 · see citing works

Census and evaluation of p53 target genes

Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971 · see citing works

Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM

Engeland, K. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.172 · Cited by 656 · see citing works

microRNAs join the p53 network — another piece in the tumour-suppression puzzle

He, L., He, X., Lowe, S. W., & Hannon, G. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2232 · Cited by 546 · see citing works

p53 Enters the MicroRNA World

Hermeking, H. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.028 · Cited by 494 · see citing works

Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks

Fischer, M., Grossmann, P., Padi, M., & DeCaprio, J. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw523 · Cited by 330 · see citing works

The Guardian's Little Helper: MicroRNAs in the p53 Tumor Suppressor Network

He, X., He, L., & Hannon, G. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2672 · Cited by 317 · see citing works

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

Akamatsu, S., Wyatt, A. W., Lin, D., Lysakowski, S., Zhang, F., Kim, S., Tse, C., Wang, K., Mo, F., Haegert, A. M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.012 · Cited by 281 · see citing works

Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes.

Fischer, M., & Müller, G. A. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1360836 · Cited by 255 · see citing works

The diverse consequences of aneuploidy

Chunduri, N. K., & Štorchová, Z. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0243-8 · Cited by 207 · see citing works

Tumour suppression by p53: the importance of apoptosis and cellular senescence

Zuckerman, V., Wolyniec, K., Sionov, R. V., Haupt, S., & Haupt, Y. (2009) · The Journal of Pathology · doi:10.1002/path.2584 · Cited by 210 · see citing works

FOX(M1) News—It Is Cancer

Halasi, M., & Gartel, A. L. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0712 · Cited by 210 · see citing works

A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma

Salvatore, G., Nappi, T. C., Salerno, P., Jiang, Y., Garbi, C., Ugolini, C., Miccoli, P., Basolo, F., Castellone, M. D., Cirafici, A. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1887 · Cited by 186 · see citing works

FOXM1 (Forkhead box M1) in Tumorigenesis

Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 183 · see citing works

The Transcription Factor FOXM1 (Forkhead box M1)

Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407173-5.00004-2 · Cited by 174 · see citing works

Pro-proliferative FoxM1 is a target of p53-mediated repression

Barsotti, A. M., & Prives, C. L. (2009) · Oncogene · doi:10.1038/onc.2009.282 · Cited by 166 · see citing works

The role of DNA damage responses in p53 biology

Speidel, D. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1459-z · Cited by 165 · see citing works

Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer

Caldon, C. E., & Musgrove, E. A. (2010) · Cell Division · doi:10.1186/1747-1028-5-2 · Cited by 146 · see citing works

Emerging complexity of microRNA generation cascades

Suzuki, H. I., & Miyazono, K. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq113 · Cited by 135 · see citing works

Cdc7-Dbf4 Kinase Overexpression in Multiple Cancers and Tumor Cell Lines Is Correlated with p53 Inactivation

Bonte, D., Lindvall, C. J., Liu, H., Dykema, K. J., Furge, K., & Weinreich, M. (2008) · Neoplasia · doi:10.1593/neo.08216 · Cited by 133 · see citing works

TP53mutations, expression and interaction networks in human cancers

Wang, X., & Sun, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.13483 · Cited by 132 · see citing works

Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes

Walters, K., Syder, A. J., Lederer, S., Diamond, D. L., Paeper, B. W., Rice, C. M., & Katze, M. G. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000269 · Cited by 120 · see citing works

Redefining the p53 response element

Wang, B., Xiao, Z., & Ren, E. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903284106 · Cited by 116 · see citing works

Pharmacological CDK4/6 inhibition reveals a p53‐dependent senescent state with restricted toxicity

Wang, B., Varela‐Eirin, M., Brandenburg, S. M., Hernandez‐Segura, A., van Vliet, T., Jongbloed, E. M., Wilting, S. M., Ohtani, N., Jager, A., & Demaria, M. (2022) · The EMBO Journal · doi:10.15252/embj.2021108946 · Cited by 113 · see citing works

Distinct mechanisms act in concert to mediate cell cycle arrest

Toettcher, J. E., Loewer, A., Ostheimer, G. J., Yaffe, M. B., Tidor, B., & Lahav, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806196106 · Cited by 112 · see citing works

Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats

Taylor, S., Ominsky, M. S., Hu, R., Pacheco, E., He, Y. D., Brown, D. L., Aguirre, J. I., Wronski, T. J., Buntich, S., Afshari, C. A., et al. (2016) · Bone · doi:10.1016/j.bone.2015.12.013 · Cited by 106 · see citing works

Expression of Androgen Receptor Is Negatively Regulated By p53

Alimirah, F., Panchanathan, R., Chen, J., Zhang, X., Ho, S., & Choubey, D. (2007) · Neoplasia · doi:10.1593/neo.07769 · Cited by 110 · see citing works

RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53

Sohr, S., & Engeland, K. (2008) · Cell Cycle · doi:10.4161/cc.7.21.7014 · Cited by 99 · see citing works

p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes

Benson, E. K., Mungamuri, S. K., Attie, O., Kracikova, M., Sachidanandam, R., Manfredi, J. J., & Aaronson, S. A. (2013) · Oncogene · doi:10.1038/onc.2013.378 · Cited by 95 · see citing works

Hitting cancers’ weak spots: vulnerabilities imposed by p53 mutation

Gurpinar, E., & Vousden, K. H. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.04.001 · Cited by 94 · see citing works

Identification of potential synthetic lethal genes to p53 using a computational biology approach

Wang, X., & Simon, R. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-30 · Cited by 91 · see citing works

p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA

Yu, F., Bracken, C. P., Pillman, K. A., Lawrence, D., Goodall, G. J., Callen, D. F., & Neilsen, P. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129190 · Cited by 89 · see citing works

Senescence induction; a possible cancer therapy

LLeonart, M. E., Artero‐Castro, A., & Kondoh, H. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-3 · Cited by 87 · see citing works

Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells

Lok, G. T. M., Chan, D. W., Liu, V. W. S., Hui, W. W. Y., Leung, T. H. Y., Yao, K., & Ngan, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023790 · Cited by 77 · see citing works

Wip1 confers G2 checkpoint recovery competence by counteracting p53‐dependent transcriptional repression

Lindqvist, A., de Bruijn, M., Macurek, L., Brás, A., Mensinga, A., Bruinsma, W., Voets, O., Kranenburg, O., & Medema, R. H. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.246 · Cited by 75 · see citing works

Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells

Junk, D. J., Vrba, L., Watts, G. S., Oshiro, M. M., Martinez, J. D., & Futscher, B. W. (2008) · Neoplasia · doi:10.1593/neo.08120 · Cited by 74 · see citing works

p53- and p21-dependent premature APC/C–Cdh1 activation in G2 is part of the long-term response to genotoxic stress

Wiebusch, L., & Hagemeier, C. (2010) · Oncogene · doi:10.1038/onc.2010.99 · Cited by 73 · see citing works

Wild-type p53 and p73 negatively regulate expression of proliferation related genes

Scian, M. J., Carchman, E. H., Mohanraj, L., Stagliano, K. E., Anderson, M. A. E., Deb, D., Crane, B., Kiyono, T., Windle, B. E., Deb, S., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210898 · Cited by 71 · see citing works

p53 and Cell Cycle Dependent Transcription of kinesin family member 23 (KIF23) Is Controlled Via a CHR Promoter Element Bound by DREAM and MMB Complexes

Fischer, M., Grundke, I., Sohr, S., Quaas, M., Hoffmann, S., Knörck, A., Gumhold, C., & Rother, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063187 · Cited by 64 · see citing works

Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein

Fischer, M., Quaas, M., Wintsche, A., Müller, G. A., & Engeland, K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt849 · Cited by 62 · see citing works

One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor

Böhlig, L., & Rother, K. (2011) · BioMed Research International · doi:10.1155/2011/464916 · Cited by 58 · see citing works

p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma

Meley, D., Spiller, D. G., White, M., McDowell, H. P., Pizer, B. L., & Sée, V. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.16 · Cited by 55 · see citing works

Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage

Wilson, P. M., Fazzone, W., LaBonte, M. J., Lenz, H., & Ladner, R. D. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn910 · Cited by 56 · see citing works

To repress or not to repress: This is the guardian's question

Rinn, J. L., & Huarte, M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.04.002 · Cited by 56 · see citing works

Δ40 Isoform of p53 Controls β-Cell Proliferation and Glucose Homeostasis in Mice

Hinault, C., Kawamori, D., Liew, C. W., Maier, B., Hu, J., Keller, S. R., Mirmira, R. G., Scrable, H. J., & Kulkarni, R. (2011) · Diabetes · doi:10.2337/db09-1379 · Cited by 56 · see citing works

Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex

Kandhaya‐Pillai, R., Miró‐Mur, F., Alijotas‐Reig, J., Tchkonia, T., Schwartz, S., Kirkland, J. L., & Oshima, J. (2023) · Aging · doi:10.18632/aging.204743 · Cited by 53 · see citing works

The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death

Chari, N. S., Pinaire, N. L., Thorpe, L., Medeiros, L. J., Routbort, M. J., & McDonnell, T. J. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0327-9 · Cited by 54 · see citing works

Implication of human N-α-acetyltransferase 5 in cellular proliferation and carcinogenesis

Ametzazurra, A., Larrea, E., Civeira, M. P., Prìeto, J., & Aldabe, R. (2008) · Oncogene · doi:10.1038/onc.2008.332 · Cited by 53 · see citing works

NGF-mediated transcriptional targets of p53 in PC12 neuronal differentiation

Brynczka, C., Labhart, P., & Merrick, B. A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-139 · Cited by 53 · see citing works

MicroRNAs, wild-type and mutant p53: More questions than answers

Jones, M. F., & Lal, A. (2012) · RNA Biology · doi:10.4161/rna.20146 · Cited by 53 · see citing works

miRNA-regulated expression of oncogenes and tumor suppressor genes in the cisplatin-inhibited growth of K562 cells

Xie (2010) · Oncology Reports · doi:10.3892/or_00000813 · Cited by 49 · see citing works

p53 gain‐of‐function mutations increase Cdc7‐dependent replication initiation

Datta, A., Ghatak, D., Das, S., Banerjee, T., Paul, A., Butti, R., Gorain, M., Ghuwalewala, S., Roychowdhury, A., Alam, S. K., et al. (2017) · EMBO Reports · doi:10.15252/embr.201643347 · Cited by 47 · see citing works

Dissecting microregulation of a master regulatory network

Sinha, A. U., Kaimal, V., Chen, J., & Jegga, A. G. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-88 · Cited by 44 · see citing works

miR-98 regulates cisplatin-induced A549 cell death by inhibiting TP53 pathway

Zhang, S., Zhang, C., Li, Y., Wang, P., Yue, Z., & Xie, S. (2011) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2011.04.010 · Cited by 43 · see citing works

Integrative Genomics Identified RFC3 As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma

Lockwood, W. W., Thu, K. L., Lin, L., Pikor, L. A., Chari, R., Lam, W. L., & Beer, D. G. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1431 · Cited by 43 · see citing works

Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest

Levesque, A. A., Fanous, A. A., Poh, A., & Eastman, A. R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2066 · Cited by 43 · see citing works

Genetic Networks Lead and Follow Tumor Development: MicroRNA Regulation of Cell Cycle and Apoptosis in the p53 Pathways

Otsuka, K., & Ochiya, T. (2014) · BioMed Research International · doi:10.1155/2014/749724 · Cited by 42 · see citing works

Development and Validation of a Prognostic Gene-Expression Signature for Lung Adenocarcinoma

Park, Y.-Y., Park, E. S., Kim, S. B., Kim, S. C., Sohn, B. H., Chu, I., Jeong, W., Mills, G. B., Byers, L. A., & Lee, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044225 · Cited by 41 · see citing works

A p53 Drug Response Signature Identifies Prognostic Genes in High-Risk Neuroblastoma

Barbieri, E., Preter, K. D., Capasso, M., Johansson, P. A., Man, T., Chen, Z., Stowers, P. N., Tonini, G. P., Speleman, F., & Shohet, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079843 · Cited by 38 · see citing works

A global toxicogenomic analysis investigating the mechanistic differences between tobacco and marijuana smoke condensates in vitro

Maertens, R. M., White, P. A., Williams, A., & Yauk, C. L. (2013) · Toxicology · doi:10.1016/j.tox.2013.03.008 · Cited by 38 · see citing works

Tousled‐like kinase 2 regulates recovery from a DNA damage‐induced G2 arrest

Bruinsma, W., van den Berg, J., Aprelia, M., & Medema, R. H. (2016) · EMBO Reports · doi:10.15252/embr.201540767 · Cited by 36 · see citing works

E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53

Bajaj, S., Alam, S. K., Roy, K. S., Datta, A., Nath, S., & Roychoudhury, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731398 · Cited by 36 · see citing works

The p53 Pathway Encounters the MicroRNA World

Takwi, A. A., & Li, Y. (2009) · Current Genomics · doi:10.2174/138920209788185270 · Cited by 34 · see citing works

Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies

Jaune, E., Cavazza, E., Ronco, C., Grytsai, O., Abbe, P., Tekaya, N., Zerhouni, M., Béranger, G. E., Kaminski, L., Bost, F., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03344-6 · Cited by 33 · see citing works

The Adenoviral E1B 55-Kilodalton Protein Controls Expression of Immune Response Genes but Not p53-Dependent Transcription

Miller, D. L., Rickards, B., Mashiba, M., Huang, W., & Flint, S. J. (2009) · Journal of Virology · doi:10.1128/jvi.02269-08 · Cited by 33 · see citing works

IPH-926 lobular breast cancer cells harbor a p53 mutant with temperature-sensitive functional activity and allow for profiling of p53-responsive genes

Christgen, M., Noskowicz, M., Heil, C., Schipper, E., Christgen, H., Geffers, R., Kreipe, H. H., & Lehmann, U. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.126 · Cited by 31 · see citing works

Transcriptional control of the proliferation cluster by the tumor suppressor p53

Brosh, R., & Rotter, V. (2009) · Molecular BioSystems · doi:10.1039/b911416e · Cited by 30 · see citing works

Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer

Kawai, Y., Imada, K., Akamatsu, S., Zhang, F., Seiler, R., Hayashi, T., Leong, J., Beraldi, E., Saxena, N., Kretschmer, A., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-1031 · Cited by 27 · see citing works

Tuftsin Augments Antitumor Efficacy of Liposomized Etoposide against Fibrosarcoma in Swiss Albino Mice

Khan, M. A., Khan, A. A., Dwivedi, V., Ahmad, M., Hakeem, S., & Owais, M. (2007) · Molecular Medicine · doi:10.2119/2007-00018.khan · Cited by 26 · see citing works

RGS16, a novel p53 and pRb cross-talk candidate inhibits migration and invasion of pancreatic cancer cells

Carper, M. B., Denvir, J., Bošković, G., Primerano, D. A., & Claudio, P. P. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.43 · Cited by 25 · see citing works

Inactivation of Both FHIT and p53 Cooperate in Deregulating Proliferation-Related Pathways in Lung Cancer

Andriani, F., Roz, E., Caserini, R., Conte, D., Pastorino, U., Sozzi, G., & Roz, L. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318244aed0 · Cited by 24 · see citing works

NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS

Chattopadhyay, M., Kodela, R., Santiago, G., Le, T. T. C., Nath, N., & Kashfi, K. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113857 · Cited by 22 · see citing works

Overexpression of RFC3 is correlated with ovarian tumor development and poor prognosis

Shen, H., Cai, M., Zhao, S., Wang, H., Li, M., Yao, S., & Jiang, N. (2014) · Tumor Biology · doi:10.1007/s13277-014-2216-2 · Cited by 22 · see citing works

RHAMM splice variants confer radiosensitivity in human breast cancer cell lines

Schütze, A., Vogeley, C., Gorges, T. M., Twarock, S., Butschan, J., Babayan, A., Klein, D., Knauer, S. K., Metzen, E., Müller, V., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7258 · Cited by 21 · see citing works

Nuclear Factor-Y in Mouse Pancreatic β-Cells Plays a Crucial Role in Glucose Homeostasis by Regulating β-Cell Mass and Insulin Secretion

Liu, Y., He, S., Zhou, R., Zhang, X., Yang, S., Deng, D., Zhang, C., Yu, X., Chen, Y., & Su, Z. (2021) · Diabetes · doi:10.2337/db20-1238 · Cited by 19 · see citing works

Inhibition of Ganglioside Synthesis Suppressed Liver Cancer Cell Proliferation through Targeting Kinetochore Metaphase Signaling

Su, T., Qin, X., Dohmae, N., Wei, F., Furutani, Y., Kojima, S., & Yu, W. (2021) · Metabolites · doi:10.3390/metabo11030167 · Cited by 19 · see citing works

Functional Genomics and a New Era in Radiation Biology and Oncology

Amundson, S. A. (2008) · BioScience · doi:10.1641/b580606 · Cited by 19 · see citing works

Quantitative model for inferring dynamic regulation of the tumour suppressor gene p53

Wang, J., & Tian, T. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-36 · Cited by 19 · see citing works

p53‐dependent up‐regulation of CDKN 1A and down‐regulation of CCNE 2 in response to beryllium

Gorjala, P., Cairncross, J. G., & Gary, R. K. (2016) · Cell Proliferation · doi:10.1111/cpr.12291 · Cited by 18 · see citing works

miR-30e controls DNA damage-induced stress responses by modulating expression of the CDK inhibitor p21WAF1/CIP1 and caspase-3

Sohn, D., Peters, D., Piekorz, R. P., Budach, W., & Jänicke, R. U. (2016) · Oncotarget · doi:10.18632/oncotarget.7432 · Cited by 17 · see citing works

Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation

Busch, M. A., Schwindt, H., Brandt, A., Beier, M., Görldt, N., Romaniuk, P. J., Toska, E., Roberts, S. G. E., Royer, H., & Royer‐Pokora, B. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu111 · Cited by 16 · see citing works

Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis

Lindgren, T., Stigbrand, T. I., Riklund, K., Johansson, L. F., & Eriksson, D. (2012) · Tumor Biology · doi:10.1007/s13277-012-0329-z · Cited by 15 · see citing works

Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia

Abramowitz, J., Neuman, T., Perlman, R., & Ben‐Yehuda, D. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0249-2 · Cited by 14 · see citing works

Heterogeneity of p53 dependent genomic responses following ethanol exposure in a developmental mouse model of fetal alcohol spectrum disorder

Moreno, M. C., Mooney, S. M., & Middleton, F. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180873 · Cited by 13 · see citing works

Unmet Expectations: miR-34 Plays No Role in p53-Mediated Tumor Suppression In Vivo

Jain, A. K., & Barton, M. C. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002859 · Cited by 12 · see citing works

Wild Type p53 Transcriptionally Represses the SALL2 Transcription Factor under Genotoxic Stress

Farkas, C., Martins, C. P., Escobar, D., Hepp, M. I., Donner, D. B., Castro, A. F., Evan, G. I., Gutiérrez, J. L., Warren, R. S., & Pincheira, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073817 · Cited by 12 · see citing works

Tumor suppressor p53 down-regulates expression of human leukocyte marker CD43 in non-hematopoietic tumor cells

Kadaja, L. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1208 · Cited by 9 · see citing works

miR‑181b‑p53 negative feedback axis regulates osteosarcoma cell proliferation and invasion

Wan, J., Long, F., Zhang, C., & Liu, Y. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4558 · Cited by 9 · see citing works

Effect of polyamine deficiency on proteins involved in Okazaki fragment maturation

Johansson, V. M., Miniotis, M. F., Hegardt, C., Jönsson, G. B., Staaf, J., Berntsson, P., Oredsson, S., & Alm, K. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.08.018 · Cited by 8 · see citing works

Transcriptional regulation underlying recovery from a DNA damage-induced arrest

Álvarez‐Fernández, M., Medema, R. H., & Lindqvist, A. (2010) · Transcription · doi:10.4161/trns.1.1.12063 · Cited by 6 · see citing works

The expression of p53 and p16 in the course of microcystin-LR inducing of liver tumor

Hu, Z., Chen, H., Pang, C., & Lin, Q. (2008) · The Chinese-German Journal of Clinical Oncology · doi:10.1007/s10330-008-0137-5 · Cited by 4 · see citing works

p53 Inhibition in Pancreatic Progenitors Enhances the Differentiation of Human Pluripotent Stem Cells into Pancreatic β-Cells

Aigha, I. I., & Abdelalim, E. M. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10509-1 · Cited by 3 · see citing works

Normal-like breast cells, but not breast cancer cells, recovered from treatment with N′,N′′-diethylnorspermine

Myhre, L., Alm, K., Johansson, M. C., & Oredsson, S. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328323fc98 · Cited by 3 · see citing works

Effect of p53 genotype on gene expression profiles in murine liver

Morris, S. M., Akerman, G. S., Desai, V. G., Tsai, C., Tolleson, W. H., Melchior, W. B., Lin, C., Fuscoe, J. C., Casciano, D. A., & Chen, J. J. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.12.004 · Cited by 3 · see citing works

Complexity of Stress Signaling

Hyduke, D. R., Amundson, S. A., & Fornace, A. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00257-6 · Cited by 3 · see citing works

MicroRNAs in Cancer (An Overview)

Ferracin, M., Călin, G. A., & Negrini, M. (2010) · Springer eBooks · doi:10.1007/978-94-007-0298-1_1 · Cited by 2 · see citing works

Identification of the p53-Responsive Element in the Promoter Region of the Human Decorin Gene

Hiwasa, T. (2015) · Molecular Biology · doi:10.4172/2168-9547.1000124 · Cited by 2 · see citing works

Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progression

Guo, Z., & Guo, L. (2024) · International Journal of Clinical Oncology · doi:10.1007/s10147-024-02478-3 · Cited by 2 · see citing works

An AI-guided framework reveals conserved features governing microRNA strand selection

Meadows, D., Hargis, H., Ellis, A. V., Lee, H., & Mangone, M. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1510 · Cited by 1 · see citing works

Tp53-dependent repression of cell cycle target genes: Global and mechanistic analysis

Spurgers, K. B. (2006) · Digital Commons-TMC (Texas Medical Center)

Cell cycle regulatory genes are principal targets of p53-dependent, RB-mediated transcriptional repression following DNA damage

Spurgers, K. B., Rolle, G., Gold, D. L., Bohnenstiehl, N. L., Coombes, K. R., Meyn, R. E., Logothetis, C. J., & McDonnell, T. J. (2006) · Cancer Research

The p53 response element and transcriptional repression

Wang, B., Xiao, Z., Ko, H. L., & Ren, E.-C. (2010) · Cell Cycle · doi:10.4161/cc.9.5.10825 · Cited by 90 · see citing works

Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression

Mirza, A., Wu, Q. J., Wang, L., McClanahan, T., Bishop, W. R., Gheyas, F., Ding, W., Hutchins, B., Hockenberry, T., Kirschmeier, P. T., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206477 · Cited by 183 · see citing works

Microarray Approaches for Analysis of Cell Cycle Regulatory Genes

Amundson, S. A., & Fornace, A. J. (2004) · Humana Press eBooks · doi:10.1385/1-59259-646-0:125 · Cited by 5 · see citing works